SPARQL
Query
Update
Search
Quick
Advanced
Co-occurrence
RelFinder
About
Sources
Admin
System Info
Repository Management
Search Configuration
Sources
18477422
Source:
http://linkedlifedata.com/resource/pubmed/id/18477422
Search
Subject
(
54
)
Predicate
Object
All
Download in:
JSON
RDF
N3/Turtle
N-Triples
Switch to
Custom View
Named Graph
All
UniProt
NCBIGene
DrugBank
ClinicalTrials
UMLS
PubMed
Mappings
MentionedEntities
Language
All
English
Español
Português
Français
Deutsch
Русский
日本語
Български
Inference
Explicit and implicit
Explicit only
Implicit only
Statements in which the resource exists as a subject.
Predicate
Object
rdf:type
pubmed:Citation
lifeskim:mentions
umls-concept:C0017480
,
umls-concept:C0087111
,
umls-concept:C0680954
,
umls-concept:C1120386
,
umls-concept:C1145701
,
umls-concept:C1609535
pubmed:issue
6
pubmed:dateCreated
2008-6-18
pubmed:abstractText
To investigate the economic impact of micafungin (MICA) for treatment of invasive candidiasis and candidaemia (systemic Candida infections), a health economic analysis was conducted comparing MICA with liposomal amphotericin B (L-AMB).
pubmed:language
eng
pubmed:journal
http://linkedlifedata.com/resource/pubmed/journal/0351014
pubmed:citationSubset
IM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/Amphotericin B
,
http://linkedlifedata.com/resource/pubmed/chemical/Antifungal Agents
,
http://linkedlifedata.com/resource/pubmed/chemical/Echinocandins
,
http://linkedlifedata.com/resource/pubmed/chemical/Lipopeptides
,
http://linkedlifedata.com/resource/pubmed/chemical/Lipoproteins
,
http://linkedlifedata.com/resource/pubmed/chemical/liposomal amphotericin B
,
http://linkedlifedata.com/resource/pubmed/chemical/micafungin
pubmed:status
MEDLINE
pubmed:month
Jun
pubmed:issn
1473-4877
pubmed:author
pubmed-author:CornelyO AOA
,
pubmed-author:OdeyemiII
,
pubmed-author:SchoemanOO
,
pubmed-author:SidhuMM
,
pubmed-author:van EngenA KAK
,
pubmed-author:van der WaalJ MJM
pubmed:issnType
Electronic
pubmed:volume
24
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
1743-53
pubmed:dateRevised
2008-11-21
pubmed:meshHeading
pubmed-meshheading:18477422-Amphotericin B
,
pubmed-meshheading:18477422-Antifungal Agents
,
pubmed-meshheading:18477422-Candidiasis
,
pubmed-meshheading:18477422-Cost-Benefit Analysis
,
pubmed-meshheading:18477422-Double-Blind Method
,
pubmed-meshheading:18477422-Echinocandins
,
pubmed-meshheading:18477422-Germany
,
pubmed-meshheading:18477422-Humans
,
pubmed-meshheading:18477422-Lipopeptides
,
pubmed-meshheading:18477422-Lipoproteins
,
pubmed-meshheading:18477422-Models, Economic
,
pubmed-meshheading:18477422-Outcome Assessment (Health Care)
,
pubmed-meshheading:18477422-Randomized Controlled Trials as Topic
pubmed:year
2008
pubmed:articleTitle
Economic analysis of micafungin versus liposomal amphotericin B for treatment of candidaemia and invasive candidiasis in Germany.
pubmed:affiliation
Klinikum der Universität, Kerpener Strasse 62, 50924, Köln, Germany.
pubmed:publicationType
Journal Article
,
Comparative Study
,
Research Support, Non-U.S. Gov't